BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10047665)

  • 1. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer.
    Suzuki K; Nagai K; Yoshida J; Nishimura M; Takahashi K; Nishiwaki Y
    J Thorac Cardiovasc Surg; 1999 Mar; 117(3):593-8. PubMed ID: 10047665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving clinical efficacy of computed tomographic scan in the preoperative assessment of patients with non-small cell lung cancer.
    Ratto GB; Frola C; Cantoni S; Motta G
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):416-25. PubMed ID: 2155357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer.
    Takamochi K; Nagai K; Yoshida J; Suzuki K; Ohde Y; Nishimura M; Takahashi K; Nishiwaki Y
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1135-40. PubMed ID: 10838529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of N2 disease in non-small cell lung cancer.
    Takamochi K; Nagai K; Suzuki K; Yoshida J; Ohde Y; Nishiwaki Y
    Chest; 2000 Jun; 117(6):1577-82. PubMed ID: 10858386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings.
    Takamochi K; Nagai K; Yoshida J; Suzuki K; Ohde Y; Nishimura M; Sasaki S; Nishiwaki Y
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):325-30. PubMed ID: 11479506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
    J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis and histologic features of small pulmonary adenocarcinoma based on serum carcinoembryonic antigen level and computed tomographic findings.
    Takamochi K; Yoshida J; Nishimura M; Yokose T; Sasaki S; Nishiwaki Y; Suzuki K; Nagai K
    Eur J Cardiothorac Surg; 2004 May; 25(5):877-83. PubMed ID: 15082298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tumor size of small lung adenocarcinomas evaluated with mediastinal window settings on computed tomography.
    Sakao Y; Kuroda H; Mun M; Uehara H; Motoi N; Ishikawa Y; Nakagawa K; Okumura S
    PLoS One; 2014; 9(11):e110305. PubMed ID: 25365326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.
    Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):574-9. PubMed ID: 22689182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prediction model for N2 disease in T1 non-small cell lung cancer.
    Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Tsubota N
    Ann Thorac Surg; 2003 Dec; 76(6):1828-32; discussion 1832. PubMed ID: 14667592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.
    Ye B; Cheng M; Ge XX; Geng JF; Li W; Feng J; Hu DZ; Zhao H
    World J Surg Oncol; 2014 Feb; 12():42. PubMed ID: 24559138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
    Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
    J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N2 lung cancer: outcome in patients with false-negative computed tomographic scans of the chest.
    Daly BD; Mueller JD; Faling LJ; Diehl JT; Bankoff MS; Karp DD; Rand WM
    J Thorac Cardiovasc Surg; 1993 May; 105(5):904-10; discussion 910-1. PubMed ID: 8487569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.
    Liu Y; Kim J; Balagurunathan Y; Hawkins S; Stringfield O; Schabath MB; Li Q; Qu F; Liu S; Garcia AL; Ye Z; Gillies RJ
    Med Phys; 2018 Jun; 45(6):2518-2526. PubMed ID: 29624702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases.
    Fernandez FG; Kozower BD; Crabtree TD; Force SD; Lau C; Pickens A; Krupnick AS; Veeramachaneni N; Patterson GA; Jones DR; Meyers BF
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):35-41, 42.e1. PubMed ID: 25439769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.